Announce Date | 04/24/2025 |
EPS Normalized Actual | $0.27 (Miss by $-1.46) |
EPS GAAP Actual | $0.27 (Miss by $-1.46) |
Revenue Actual | $0.226218B |
Revenue Surprise | Beat by $226.218M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.3075 |
EPS GAAP Estimate | $0.3075 |
Revenue Estimate | $1.450539102B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 2.53 | 65.84 | 2.44089 | 2.71319 | 3 |
Dec 2028 | 2.36 | 70.58 | 2.25286 | 2.45579 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.099 | -0.3865 | 0.226218B | -488.43% | -1198.07M |
FQ4 2024 (Dec 2024) | -0.27 | -0.59543 | 0.215331B | -536.06% | -1203.09M |
FQ3 2024 (Sep 2024) | -0.137 | -1.67841 | 0.21334B | -557.37% | -2591.53M |
FQ2 2024 (Jun 2024) | 0.25 | 0.25 | 1.35675B | -0.7% | 1356.75M |
FQ1 2024 (Mar 2024) | 0.9 | 0.9 | 1.33114B | -0.57% | 1331.14M |
FQ4 2023 (Dec 2023) | 0.0899 | 0.0899 | 1.36963B | 9.97% | 1369.63M |
FQ3 2023 (Sep 2023) | 2.4 | 2.4 | 1.40244B | 15% | 1402.44M |
FQ2 2023 (Jun 2023) | 0.37 | 0.37 | 1.36627B | 16.61% | 1366.27M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.3075
Consensus Revenue Estimates
1.450539102B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 0 | -- | 0 | 0 | 3 |
FQ3 2026 (Jul 2026) | 0 | -- | 0 | 0 | 4 |
FQ2 2026 (Jun 2026) | 0 | -- | 0 | 0 | 3 |
FQ1 2026 (Mar 2026) | 0 | INF | 0 | 0 | 6 |
FQ4 2025 (Oct 2025) | 0.33 | 181.82 | 0.32685 | 0.33526 | 3 |
FQ3 2025 (Jul 2025) | 0.33667 | 140.69 | 0.33346 | 0.34204 | 3 |
FQ2 2025 (Jun 2025) | 0.3075 | 18.7 | 0.30368 | 0.31358 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 1.6B | -- | 1.59B | 1.62B | 4 |
FQ3 2026 (Jul 2026) | 1.53B | -- | 1.52B | 1.55B | 4 |
FQ2 2026 (Jun 2026) | 1.46B | -- | 1.45B | 1.48B | 4 |
FQ1 2026 (Mar 2026) | 1.42B | 84.04 | 1.4B | 1.44B | 7 |
FQ4 2025 (Oct 2025) | 1.5B | 85.65 | 1.49B | 1.52B | 2 |
FQ3 2025 (Jul 2025) | 1.47B | 85.44 | 1.45B | 1.48B | 2 |
FQ2 2025 (Jun 2025) | 1.45B | 6.47 | 1.44B | 1.47B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.2875 | -0.099 | -0.3865 | 390.4% |
FQ4 2024 (Dec 2024) | 0.32543 | -0.27 | -0.59543 | 220.53% |
FQ3 2024 (Sep 2024) | 1.54141 | -0.137 | -1.67841 | 1225.12% |
FQ2 2024 (Jun 2024) | 0.25 | 0.25 | 100% | |
FQ1 2024 (Mar 2024) | 0.9 | 0.9 | 100% | |
FQ4 2023 (Dec 2023) | 0.0899 | 0.0899 | 100% | |
FQ3 2023 (Sep 2023) | 2.4 | 2.4 | 100% | |
FQ2 2023 (Jun 2023) | 0.37 | 0.37 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.42B | $0.23B | $-1198.07M | -529.61% |
FQ4 2024 (Dec 2024) | $1.42B | $0.22B | $-1203.09M | -558.71% |
FQ3 2024 (Sep 2024) | $2.8B | $0.21B | $-2591.53M | -1214.74% |
FQ2 2024 (Jun 2024) | $0B | $1.36B | $1356.75M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.33B | $1331.14M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.37B | $1369.63M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.4B | $1402.44M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.37B | $1366.27M | 100% |